Novo shares rise over 5% after fight against generics

On Monday, Novo Nordisk’s stock rose by 5.3%, making it the highest riser on the Danish C25 index. This increase adds 69.2 billion DKK to its market value, according to MarketWire. The rise follows Hims & Hers’ announcement that it will not sell a copy of Novo’s Wegovy pill. Novo Nordisk is suing Hims & […]